Unlike in many solid tumors, which commonly evade apoptosis through mutations in p53 or disabling p53 dependent apoptotic signaling in p53 wild-type tumors25, most treatment naïve AML patients present with wild-type p53 tumors46,47. Here, TP53 is linked to acute myeloid leukemia.